Legal Opinion

Dilbeck v. Prinston Pharmaceutical Inc

District Court, D. New Jersey

Decided July 16, 2019No. 1:19-cv-15443Unknown

1Opinion

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: VALSARTAN PRODUCTS LIABILITY LITIGATION MDL No. 2875 (SEE ATTACHED SCHEDULE) CONDITIONAL TRANSFER ORDER (CTO —8) On February 14, 2019, the Panel transferred 5 civil action(s) to the United States District Court for the District of New Jersey for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See

363 F.Supp.3d 1378

(J.P.M.L. 2019). Since that time, 30 additional action(s) have been transferred to the District of New Jersey. With the consent of that court, all such actions have been assigned to the…

2Cases cited1 opinion

  1. In re Valsartan N-Nitrosodimethylamine (Ndma) Contamination Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2019

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API